Welcome to this week's Chutes and Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email) or Eric Sagonowsky (email) and we will feature it here at the end of each week.
Frank Nestle will head immunology and inflammation arm at Sanofi
Sanofi
Frank Nestle joined as global head of immunology and inflammation and North American chief scientific officer.
A former King's College London professor of dermatology and immunology and an ex-executive at the Biomedical Research Center in the U.K., Nestle is stepping into the Sanofi research spot to lead the company's efforts in chronic inflammatory and autoimmune diseases.
BeiGene brings on Jane Huang as chief medical officer of hematology
BeiGene
Jane Huang joins as chief medical officer in charge of hematology.
The hematology expert will join BeiGene to lead the global clinical development of the company's BTK inhibitor BGB-3111 and other drugs to treat hematological malignancies and disorders. Release
Pfizer appoints Ole Isacson to lead its neuroscience research unit
Pfizer
Ole Isacson will serve as the company's chief scientific officer in neuroscience research and senior vice president.
The Harvard professor of neurology, who will continue to teach there, will step in at Pfizer to advance potential therapies to treat Alzheimer's disease. Release
Biotech
> Reza Zadno joined Avedro as the company's CEO. Release
> Immunotherapy specialist Aduro named Dr. Natalie Sacks its chief medical officer. Release
> Daiichi Sankyo announced its appointment of Dr. Marielle Cohard-Radice as executive vice president and global head of development. Release
Vaccines
> PaxVax hired Philip Moody as its chief financial officer. Release
Drug Delivery
> Zosano appointed Georgia Erbez as its chief business officer. Release
> Insulet brought on Trang Ly as its vice president and medical director and Brittany Bradrick as its vice president of strategy and corporate development. Release
CRO
> Italy-based CRO Cromsource has appointed Pfizer, Novartis and Paraxel vet Dr. Grzegorz Rychlik as its new chief medical officer as it beefs up its medical affairs department. FierceCRO story